Botulinum toxin A and the cutaneous nociception in humans: A prospective, double-blind, placebo-controlled, randomized study

Journal of the Neurological Sciences

Volumn 205, Issue 1, 2002, Pages 59-63

  Blersch, Wendelin ^a   Schulte Mattler, Wilhelm J ^a   Przywara, Saskia ^a   May, Arne ^a   Bigalke, Hans ^c   Wohlfarth, Kai ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c NONE

Author keywords

Botulinum neurotoxin; Nociception; Quantitative sensory testing; Thermal pain

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; ANTINOCICEPTION; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ELECTROSTIMULATION; ERYTHEMA; EVALUATION; FEMALE; FOREARM; HEAT; HEMATOMA; HUMAN; HYPESTHESIA; HYPOALGESIA; MALE; MUSCLE WEAKNESS; MYALGIA; NOCICEPTION; NORMAL HUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PARESTHESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION; FEMALE; FOREHEAD; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SENSORY THRESHOLDS;

EID: 0037116179     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00313-1     Document Type: Article

References (34)

1. Scott A.B., Rosenbaum A., Collins C. Pharmacological weakening of extra-ocular muscles. Investig. Ophthalmol. Vis. Sci. 12:1973;924-927.
2. Stanley E.F., Drachman D.B. Botulinum toxin blocks quantal but not non-quantal release of Ach at the neuromuscular junction. Brain Res. 261:1983;172-175.
3. Tsui J.K., Eisen A., Stoessl A.J., Calne S., Calne D.B. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet. 2(8501):1986;245-247.
4. Schulte-Mattler W.J., Wieser T., Zierz S. Treatment of tension-type headache with botulinum toxin: a pilot study. Eur. J. Med. Res. 4:1999;183-186.
5. Silberstein S., Mathew N., Saper J., Jenkins S. Botulinum toxin type A as a migraine preventive treatment. (For the BOTOX Migraine Clinical Research Group) Headache. 40:2000;445-450.
6. Porta M. A comparative trial of botulinum toxin A and methylprednisolone for the treatment of tension type headache. Curr. Rev. Pain. 4:2000;31-35.
7. Klapper J.A., Mathew N.T., Klapper A., Kailasam J. Botulinum toxin type A (BTX-A) for the prophylaxis of chronic daily headache. Cephalalgia. 20:2000;292-293.
8. Freund B.J., Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study. Headache. 40:2000;231-236.
9. Foster L., Clapp L., Marleigh E., Jabbari B. Botulinum toxin A and chronic low back pain. Neurology. 56:2001;1290-1293.
10. Hyman N., Barnes M., Bhakta B., Cozens A., Bakheit M., Kreczy-Kleedorfer B.et al. Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J. Neurol. Neurosurg. Psychiatry. 68:2000;707-712.
11. Hallet M. How does botulinum toxin work. Ann. Neurol. 48:2000;7-8.
12. Aoki K.R. Pharmacology and immunology of botulinum toxin serotypes. J. Neurol. 248(Suppl. 1):2001;I/3-I/10.
13. Kelm S., Gerats G., Chalkiadaki A., Hefter H. Reduktion von Schmerzen und Muskelspannung durch Botulinum-Toxin A. Nervenarzt. 72:2001;302-306.
14. Fowler C.J., Sitzoglou K., Ali Z., Halonen P. The conduction velocities of peripheral nerve fibres conveying sensations of warming and cooling. J. Neurol. Neurosurg. Psychiatry. 51:1988;1164-1170.
15. Martin J.H., Jessel T.M. Modality coding in the somatic sensory system. Kandel E.R., Schwartz J.H., Jessel T.M. Principles of Neural Science. 3rd ed. 1991;332-340 Appleton & Lange, East Norwalk, CT.
16. Yarnitsky D., Ochoa J.L. Warm and cold specific somatosensory systems. Psychophysical thresholds, reaction times and peripheral conduction velocities. Brain. 114:1991;1819-1826.
17. Susser E., Sprecher E., Yarnitsky D. Paradoxical heat sensation in healthy subjects: peripherally conducted by Aδ or c fibres? Brain. 122:1999;239-246.
18. Campero M., Serra J., Bostock H., Ochoa J.L. Slowly conducting afferents activated by innocuous low temperature in human skin. J. Physiol. (Lond.). 535.3:2001;855-865.
19. Campero M., Serra J., Ochoa J.L. C polymodal nociceptors activated by noxious low temperature in human skin. J. Physiol. (Lond.). 497:1996;565-572.
20. White D., Helme R.D. Release of substance P from peripheral nerve terminals following electrical stimulation of sciatic nerve. Brain Res. 336:1985;27.
21. Ishikawa H., Mitsui Y., Yoshitomi T., Mashimo K., Aoki S., Mukuno K.et al. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilatator muscles. Jpn. J. Ophthalmol. 44:2000;106-109.
22. Welch M.J., Purkiss J.R., Foster K.A. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon. 38(2):2000;245-258.
23. Yarnitsky D., Ochoa J.L. Studies of heat pain sensation in man: perception thresholds, rate of stimulus rise and reaction time. Pain. 40:1990;85-91.
24. Yarnitsky D., Sprecher E., Zaslansky R., Hemli J.A. Heat pain thresholds: normative data and repeatability. Pain. 60:1995;329-332.
25. Yarnitsky D. Quantitative sensory testing. Muscle Nerve. 20:1997;198-204.
26. Kaube H., Katsarava Z., Käufer T., Diener H.C., Ellrich J. A new method to increase nociception specificity of the human blink reflex. Clin. Neurophysiol. 111:2000;413-416.
27. Hagander L.G., Midani H.A., Kuskowski M.A., Parry G.J.G. Quantitative sensory testing: effect of site and skin temperature on thermal thresholds. Clin. Neurophysiol. 111:2000;17-22.
28. Stevens J.C., Choo K.K. Temperature sensitivity of the body surface over life span. Somatosens. Motor Res. 15(2):1998;13-28.
29. Harrison J.L., Davis K.D. Cold-evoked pain varies with skin type and cooling rate: a psychophysical study in humans. Pain. 83(2):1999;123-135.
30. Meier P.M., Berde C.B., DiCanzio J., Zurakowski D., Sethna N.F. Quantitative assessment of cutaneous thermal and vibration sensation and thermal pain detection thresholds in healthy children and adolescents. Muscle Nerve. 24:2001;1339-1345.
31. Heckmann M., Ceballos-Baumann A.O., Plewig G. Botulinum toxin A for axillary hyperhidrosis. N. Engl. J. Med. 344:2001;488-493.
32. Laubis-Herrmann U., Fries K., Topka H. Low-dose botulinum toxin-a treatment of cervical dystonia - a double-blind, randomized pilot study. Eur. Neurol. 47:2002;214-221.
33. Wohlfarth K., Goschel H., Frevert J., Dengler R., Bigalke H. Botulinum A toxins: units versus units. Naunyn Schmiedeberg's Arch. Pharmacol. 355:1997;335-340.
34. May A., Shepheard S.L., Knorr M., Effert R., Wessing A., Hargreaves R.J.et al. Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine. Brain. 121:1998;1231-1237.